Measure suboptimal biomarkers related to COVID-19
This panel contains all 18 biomarkers that are altered in COVID patients.
A significant number of individuals who had COVID-19 suffer from long term complications months and even years after the initial recovery from acute infections. Unfortunately, we still do not know why some people suffer from these complications or how to treat these symptoms.
People with suboptimal health (subhealth) issues or various diseases such as diabetes and immunodeficiencies are more likely to develop more severe symptoms and likely long term complications from COVID-19 infection. Improving these subhealth issues will improve general health and potentially reduce suffering from long COVID. These subhealth issues can be identified by various biomarkers included in this long COVID biomarker panel.
Our health is determined by the interplay between our unique genetic makeup and our modifiable factors. This dynamic interplay results in a cascade of molecular, cellular and physiological changes, which determine our health, our response to treatment for our diseases and ultimately our longevity. These dynamic changes can be monitored using laboratory tests that measure biomarkers - meaningful signals about our health.
The long COVID panel is specially designed to measure molecular and cellular functions that are altered in COVID-19 patients.
These biomarkers can tell you your wellness status, whether you need to, and how you can, intervene to reduce suboptimal health or subhealth issues that may put at at risk of developing age-related diseases to maximize your healthspan and lifespan. This panel measures molecular and cellular functions as well as modifiable factors in nine key categories that are important to health:
Different biomarkers are tested in different biomarker panels: Basic, Best Value and COVID.
|Circulating NAD (plasma NAD)||•||•||•|
|Reactive oxygen metabolites (ROM)||•||•||•|
|Total antioxidant capacity (TAC)||•||•||•|
|High sensitivity C-reactive protein (hs-CRP)||•||•||•|
|Glycated serum protein (GSP)||•||•||•|
|Low density lipoprotein (LDL)||•||•||•|
|Alkaline phosphatase (ALP)||•||•||•|
|High density lipoprotein (HDL)||•||•||•|
|Lactate dehydrogenase (LDH)||•|
*email email@example.com for more information.
Many long COVID patients do have deficiencies or abnormalities that can be revealed by the biomarker panel. Nutritional supplements, with the right type and dosage, may improve health, reduce long COVID symptoms. However, no one knows what each person really needs the most and whether the supplements are effective.
Biomarker testing helps you identify the deficiencies and abnormalities that you need to act upon the most. Its biomarkers are actionable, meaning you can take concrete steps now to correct your deficiencies. These actions include lifestyle changes such as more exercise, more sleep, diet, and biomarker-guided supplementation of nutrients that you cannot get enough from your regular foods.
Biomarker testing allows you to assess the progress you are going to make by retaking the test after concrete actions have been taken. Initiation of actions is a great first step towards your health and longevity, while monitoring your progress or lack of progress by retaking the test on a regular interval is even more critical for your long term health and your longevity. We will recommend the most appropriate time interval for you to retake the test based on your biomarker profile.
Most biomarkers in the panel panel are tested using reagents approved by the federal drug administration (FDA) or the Commission of Europe (CE), while other biomarkers are laboratory developed tests (LDT) that are thoroughly validated for their reproducibility. Client samples are always run contemporaneously with quality control samples on state-of-the-art laboratory equipment for maximum accuracy. However, all tests have a certain degree of variation and test values at the lower end may be more variable.
Test results are reported along with the best available ranges in healthy people, thus enabling meaningful assessment of baselines. Interpretation of testing results are based on data from appropriate patients with relevant diseases. In general, the results are put in four categories with color codes: normal/optimum (green), slightly deficient/elevated (yellow), moderately deficient/elevated (orange) or highly deficient/elevated (red).
The overall health/wellness is measured by our proprietary wellness index (W-Index™). Calculation of W-Index™ is based on our proprietary formula derived from artificial intelligence analysis with our extensive database on healthy and diseased subjects.
The best W-Index™ is 100 points and each biomarker deficiency/elevation would deduct a specific number of points based on the degree of deficiency/elevation. A person with a W-Index™ of 55 points or less is considered to have suboptimal health or subhealth, which may be a risk factor of many age-related chronic diseases.
|W-Index™ range||Health/Wellness status|
|85 – 100||Excellent|
|70 – 85||Very good|
|55 – 70||Fair|
|40 – 55||Poor|
It should be noted that the W-Index™ is calculated based on the tested biomarkers and may be significantly modified by other health information such as diagnosis of diseases or biomarkers that are not measured with the panels. It is important that you verify your health information that you provided to us during activation of your test kit and that are summarized at the end of this report as an Appendix. We will generate a new report for you if you update your health information.
The determination of individual biomarker categories as well as the W-Index™ is based on our current knowledge about these biomarkers and is an evolving process as new data continue to accumulate. When significant improvement occurs, your report will be updated on our website. Since you will not be automatically notified of such changes, you may want to periodically check for any potential updates on your report.